The Impact of Genomic Variability on Vaccine Efficacy against Infectious Diseases in Sub-Saharan Africa

In Sub-Saharan Africa, an area with great genetic variation and a high prevalence of infectious diseases like HIV/ AIDS, malaria, and tuberculosis, the study investigates the dramatic effects of genomic variability on vaccine efficacy against infectious diseases. Worldwide, vaccination is still a key component of controlling infectious diseases, but immune responses and vaccine efficacy are influenced by genetic variations in both pathogens and hosts. The unique genetic landscape of Sub-Saharan Africa, influenced by intricate demographic history and environmental factors, impacts disease susceptibility and vaccination reactions, necessitating customised immunisation regimens. The review emphasises that genetic polymorphisms, especially in immune-related genes such as HLA, cytokines, and innate immunity receptors, influence vaccine-induced immunity and disease consequences. Variations in the Plasmodium falciparum circumsporozoite protein gene and human immunological genes impact malaria vaccine efficacy, whereas host genetic variables also influence reactions to BCG and HIV vaccinations. The report emphasises the essential requirement for inclusive genomic research and clinical trials that accurately represent African populations to advance vaccine development and public health strategies, hence enhancing disease prevention and management in the region. Understanding the relationship between genomic variation and vaccine response is crucial for designing effective, long-lasting vaccines tailored to the specific genetic profiles of Sub-Saharan African populations.

Keywords: Genomic Variability, Vaccine Efficacy, Sub-Saharan Africa, Malaria, Host Genetic Polymorphisms.